DY, G., QS, C., WX, C., LS, Z., XS, H., QH, X., . . . XP, Z. (2024). Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer. World journal of clinical oncology, 15(4), 531. https://doi.org/10.5306/wjco.v15.i4.531
Chicago Style (17th ed.) CitationDY, Geng, et al. "Molecular Targets and Mechanisms of Different Aberrant Alternative Splicing in Metastatic Liver Cancer." World Journal of Clinical Oncology 15, no. 4 (2024): 531. https://doi.org/10.5306/wjco.v15.i4.531.
MLA (9th ed.) CitationDY, Geng, et al. "Molecular Targets and Mechanisms of Different Aberrant Alternative Splicing in Metastatic Liver Cancer." World Journal of Clinical Oncology, vol. 15, no. 4, 2024, p. 531, https://doi.org/10.5306/wjco.v15.i4.531.
Warning: These citations may not always be 100% accurate.
